CTX-321

N/A

Report date: 2026/03/17 20:00:15

Base Information

Drug NameCTX-321
Drug Alias NameCTX-321CTX321
ClassificationCell and gene therapy > Gene therapy > Gene editing > CRISPR > CRISPR-Cas9
Mechanisms of ActionApolipoprotein(a) inhibitors
TargetsApolipoprotein(a)
Therapy Area/IndicationsHyperlipoproteinemiasHypertension
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCrispr Therapeutics Ag
China Registration ClassN/A

Develop Information

Active CompaniesCrispr Therapeutics Ag
Inactive CompaniesN/A
Active IndicationsHyperlipoproteinemiasHypertension
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A